Ledipasvir-sofosbuvir in Adolescents With Chronic Hepatitis C and Hematological Malignancies Undergoing Chemotherapy
Conclusions:
Ledipasvir-sofosbuvir was well-tolerated and efficacious in adolescents with chronic HCV genotype 4 and leukemia undergoing maintenance chemotherapy. These data support the use of this interferon and ribavirin-free regimen in adolescents with hematological malignancies.
Source: Journal of Pediatric Gastroenterology and Nutrition - Category: Gastroenterology Tags: Original Articles: Hepatology Source Type: research
More News: Cancer & Oncology | Chemotherapy | Children | Chronic Leukemia | Egypt Health | Gastroenterology | Headache | Hematology | Hepatitis | Hepatitis C | Leukemia | Liver | Liver Disease | Migraine | Nutrition | Osteoarthritis | Pediatrics | Pneumonia | Study | Urology & Nephrology